Drugs & Targets FDA Approves Imlygic as First Oncolytic Viral Therapy in the U.S., for Melanoma November 03, 2015Vol.38 No.10
Drugs & Targets FDA grants priority review to MCNA in certain bladder cancer patients October 30, 2015Vol.41 No.40
Drugs & Targets Imlygic Approved as First U.S. Oncolytic Viral Cancer Therapy October 30, 2015Vol.41 No.40
A Third of Hospitals Will Drop Out of 340B if HRSA Enacts New Guidance, Survey Finds October 30, 2015Vol.41 No.40By Matthew Bin Han Ong
